Patients with cirrhosis plus COVID-19 have higher mortality rates

Patients with cirrhosis and COVID-19 had higher mortality rates than patients with COVID-19 alone, but similar rates as patients with just cirrhosis, according to research published in Gut.Jasmohan Bajaj, MD, from Virginia Commonwealth University, and colleagues wrote that patients with cirrhosis are assumed to be high-risk in the setting of COVID-19 due to immune dysfunction and altered gut-liver axis, but data are currently lacking.“The impact of COVID-19 on in-hospital outcomes in patients with cirrhosis is unclear with respect to mortality and acute-on-chronic liver failure development,”Read More

Share on facebook
Share on twitter
Share on linkedin